Range
- - -
Vol / Avg.
-/610.5K
Div / Yield
-
52 Wk
3.44 - 8
Mkt Cap
154.6M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.18
Shares
39.3M
Outstanding
39.3M
Total Float
31.9M
Sector: Health Care.Industry: Biotechnology
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lysin exebacase has a targeted spectrum of activity, meaning that it kills specific species of Staphylococci or closely related bacteria. Its IND candidate, CF-370, targets resistant gram-negative bacteria including Pseudomonas aeruginosa (P. aeruginosa). Its advanced clinical candidate, exebacase, is an investigational novel lysin that targets Staphylococcus aureus (Staph aureus), including methicillin-resistant (MRSA) strains, which causes serious infections such as bacteremia, pneumonia and osteomyelitis.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.220-0.180 0.0400
REV2.330M0-2.330M
Q4 2020Est.ActualSurprise
EPS-0.230
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CFRXContraFect0.51%154.6M

ContraFect Frequently Asked Questions

Q

How do I buy ContraFect (CFRX) stock?

A

You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ContraFect's (CFRX) competitors?

Q

What is the target price for ContraFect (CFRX) stock?

A

The latest price target for ContraFect (NASDAQ: CFRX) was reported by WBB Securities on March 31, 2021. The analyst firm set a price target for 6.50 expecting CFRX to rise to within 12 months (a possible 65.39% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ContraFect (CFRX)?

A

The stock price for ContraFect (NASDAQ: CFRX) is $3.93 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does ContraFect (CFRX) pay a dividend?

A

There are no upcoming dividends for ContraFect.

Q

When is ContraFect (NASDAQ:CFRX) reporting earnings?

A
ContraFect’s Q2 earnings are confirmed for after-market on August 13, 2021.
Q

Is ContraFect (CFRX) going to split?

A

There is no upcoming split for ContraFect.

Q

What sector and industry does ContraFect (CFRX) operate in?

A

ContraFect is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.